The intricate microenvironment of human breast tissue supports regionally distinct microbiota, which may provide new insight to cancer risk and therapy. As a follow up to the 2016 article by Julie Wolf, the role of microbes in breast cancer is revisited, with an emphasis on the role of probiotics in breast cancer prevention.

Published in Microbial Sciences

Ananda Chakrabarty, PhD, Distinguished University Professor, University of Illinois College of Medicine at Chicago, discuses how certain pathogenic bacteria, pseudomonas aeruginosa and neisseria menigitidis, secrete protein weapons (azurin and laz) to fight cancer, providing our next generation of anticancer drugs.

Published in ASM Virtual Lectures
Thursday, 08 September 2016 00:00

Lipids that live forever - TWiM 134

Design of a synchronously lysing bacterium for delivery of anti-tumor molecules in mice, and hopanoids, the lipids that live forever, brought to you by the four Microbies of TWiM.

Published in TWiM

A newly developed antifungal, isavuconazole, is as effective as an existing drug, voriconazole against invasive mold disease in cancer patients with less adverse effects. Researchers present phase III data on this new drug.

Tuesday, 20 May 2014 19:51

Microbes and Cancer

Participants discuss not only how infection with specific pathogens causes cancers but also how disruptions in the human microbiome can also cause disease.

Could the bacterial populations in your intestines predict the onset of colon cancer? Participants discuss new research in mouse models that suggests a major shift in microbial population dynamic prior to the onset of tumors as well as the general promise microbiome research holds for the diagnosis and potential management of other diseases.

TPL_asm2013_SEARCH